Global Markets Experience Mixed Trading Amid European Debt Concerns

As the European debt crisis continued to plague global investor sentiment on Monday, the NYSE and DJIA indices managed to end the day slightly higher despite choppy trading and significant losses in various sectors. The S&P 500 and Nasdaq indices also saw gains, with the S&P 500 closing at 1,162.27 and the Nasdaq at 2,495. However, the Nikkei, Hang Seng, and Shanghai Composite indices suffered sharp declines, while the FTSE-100 and DAX-30 indices fell by 1.6% and 2.2%, respectively.

Key Takeaways:

The NYSE rose 2.44 points (+0.04%) to 7,047.45, while the DJIA increased by 68.91 points (+0.6%) to 11,060.89.
The S&P 500 rose 8 points (+0.7%) to 1,162.27, while the Nasdaq gained 27 points (+1.1%) to 2,495.
Financial stocks were hit hard, with HBC, DB, UBS, and RBS suffering losses due to European banking share losses.
Chevron Corporation's shares fell due to a sales warning, while Johnson & Johnson was subject to mixed coverage in a Barron's feature.
AGU's shares fell despite a downgrade, while COF's shares saw a drop despite a purchase of ING Online facing Fed scrutiny.
RIMM's shares rose despite a mostly critical Barron's feature, while ZION was downgraded.
BPAX's shares were down despite a successful completion of the LibiGel study, while CREE's shares reversed higher after a downgrade.
ORCL's shares fluctuated after being added to Goldman Sachs' Conviction Buy list, while GLBL was acquired for $8 per share.
RXII's shares rose after favorable drug study news, while MYGN was upgraded.

Statistics:

The NYSE gained 2.44 points (+0.04%) to 7,047.45.
The DJIA increased by 68.91 points (+0.6%) to 11,060.89.
The S&P 500 rose 8 points (+0.7%) to 1,162.27.
The Nasdaq gained 27 points (+1.1%) to 2,495.
Financial stocks such as HBC, DB, UBS, and RBS fell by various percentages due to European banking share losses.
AGU's share price fell despite a downgrade.
COF's share price fell despite a purchase of ING Online facing Fed scrutiny.
RIMM's share price rose despite a mostly critical Barron's feature.
BPAX's share price was down despite a successful completion of the LibiGel study.
CREE's share price reversed higher after a downgrade.
ORCL's share price fluctuated after being added to Goldman Sachs' Conviction Buy list.
GLBL was acquired for $8 per share.
RXII's share price rose after favorable drug study news.
MYGN was upgraded.

Sources:

(MidnightTrader via COMTEX)
MarketWatch
Reuters
The Wall Street Journal
Comtex News Network, Inc. (www.mysmartrend.com)